Annual Stern Healthcare Association Conference
Advancing and AdaptinG
Join us for the 2017 Stern Healthcare Association Conference on October 27th, 2017. In a world where the healthcare landscape, both politically and scientifically, is constantly changing, business leaders must understand how to adapt to the current climate and advance the industry. The Healthcare Conference will address how technology, emerging R&D, new business models, and integrated access is meeting the needs of patients. The conference will highlight speakers from Boehringer Ingelheim, Synergy Pharma, and NYU, to name a few.
Last year's conference drew about 200 attendees, ranging from full-time and part-time students from several schools in the area to industry professionals. The conference showcased a wide variety of programming last year too, including an entrepreneurship panel and talks given by executives from Pfizer and IBM Watson.
Friday, October 27th, 2017
NYU Stern School of Business
Kaufman Management Center
44 West 4th Street
New York, NY 10012
1:00 PM - 7:00 PM
1:00 PM - 2:00 PM
1:00 PM - 2:00 PM
Opening Keynote Address
Jean-Michel Boers, President BIPI of US Human Pharmaceuticals, Boehringer Ingelheim
2:10 PM - 2:50 PM
Human-First Health Business Paradigms
Jim Curtis, Remedy Health Media
Chris Jobe, Johnson & Johnson
Ron Vianu, Spreemo Health
Laila Zemrani, Fitnescity
Julie Holcomb, Synergy Pharma
Moderated by Steve Andrzejewski, NYU Stern
4:00 PM - 4:40 PM
Fireside Chat, Policy and Politics in Healthcare
Adam Sabloff, VirtualHealth
Rishi Jaggernauth, Regeneron
4:55 PM - 5:35 PM
Closing Keynote Address
Anthony Mancini, Head, US Specialty & Puerto Rico/Caribbean Region, Bristol-Myers Squibb Company
5:40 PM - 6:15 PM
6:15 PM - 7:00 PM
President BIPI - US Human Pharmaceuticals
Jean-Michel started his career in management consulting in Munich, Germany. He joined Boehringer Ingelheim in 1998 in Belgium and has a track record of success in a number of diverse leadership roles in corporate and various countries including Corporate Vice President Marketing & Sales Effectiveness and Country Managing Director in France.
In 2014, he was assigned to lead the Prescription Medicines business within the newly created MIDI Regional Operating Unit that includes Belgium, Denmark, Finland, Greece, The Netherlands, Norway, Portugal and Sweden. In July 2016, he was appointed Senior Vice President Specialty Care for the US and in January 2017 Jean-Michel was appointed President, US Human Pharmaceuticals.
In complex markets, Jean-Michel has promoted access for, and launched, many of our company’s core products while successfully representing our company in front of external stakeholders. He has also driven the implementation of new promotional approaches in France and MIDI and has been a member of the corporate extended prescription medicines committee for more than 10 years.
A citizen of France and The Netherlands, Jean-Michel earned an MA in social and economic history from the University of Nijmegen (Netherlands) and an MBA from the University of Texas. He currently resides with his spouse Sabine and their children in Weston, Connecticut.
Head, US Specialty & Puerto Rico/Caribbean Region, Bristol-Myers Squibb Company
Anthony Mancini is the Head, US Specialty & Puerto Rico/Caribbean Region. In this role, Anthony is responsible for developing the Immunoscience & cardiovascular business units in the US by leading a strong Specialty organization towards the development and execution of a patient-focused and customer driven strategy. In addition, Anthony oversees the commercial operations in the Puerto Rico/Caribbean region.
Anthony joined Bristol-Myers Squibb in 1996 and brings a diverse leadership, operational, and strategic background, globally and in several geographies. Most recently, he was the General Manager, Australia and New Zealand where BMS is the fastest growing Pharma Company in Australia. Anthony has played an active role in shaping the industry as an elected member of the Medicines Australia Board of Directors. He was also a member of the board of directors of St. Vincent’s Medical Research Institute (SVI) in Melbourne. Thanks to high employee engagement, BMS ANZ was named an AON Hewitt Best Employer for three consecutive years.
Prior to the GM role, Anthony was part of the Global Commercialization team as Vice President, Global Commercialization, Oncology.
Anthony earned his MBA from Clemson University. As an undergraduate, he studied Biochemistry at the University of Ottawa, Canada.
Christopher S. Jobes
Director- Retail Health & Wellness, Johnson & Johnson Consumer Inc.
Chris Jobes has been with Johnson & Johnson for over 16 years. His career with J&J started as a brand marketer for consumer products. After spending 5 years in marketing, he made the move to Consumer Sales where he gained customer development expertise and transitioned into strategic development roles, having responsibility for shopper & category management, shelf design, and leading a team of analysts covering over $1B of volume.
In 2013, Chris became the first Director of Retail Health & Wellness for Johnson & Johnson. In this role, he is responsible for developing Health & Wellness strategies bringing J&J enterprise assets andinitiatives to deliver against triple aim objectives along the patient journey and path to purchase.
Prior to joining Johnson & Johnson Chris studied Cardiovascular Perfusion at Johns Hopkins Hospital and became a Board Certified Clinical Perfusionist. He spent 5 yearspracticing perfusion, finishing his clinical career asChief of Perfusion for the University of Pennsylvania Health System.
Chris earned his MBA at Saint Joseph’s University.
President, Remedy Health Media
As President, Jim is responsible for product strategy & development and audience expansion in addition to overseeing sales, business development and marketing strategy & execution across all of Remedy Health Media’s digital, mobile and point-of-care product lines. Since joining Remedy in 2010 as Chief Revenue Officer and Chief Strategy Officer, he’s played an essential role building revenue, client performance and operations teams while developing new products and growing revenues and profits for the company.
With a strong background in interactive health information and tools, Jim’s focus is on driving digital growth for the company while creating advertising solutions that leverage Remedy’s strong multi-platform media solutions.
Jim was named one of PharmaVoice’s Top 100 Most Influential and Inspirational Leaders in Health three years in a row, and recently is being honored a fourth time with their Red Jacket award. He was the recipient of PM360’s Elite Disrupter Award and MM&M’s Rising Star Award. Curtis is a public speaker, author, storyteller, and business coach.
In his debut book, The Stimulati Experience: 9 Skills for Getting Past Pain, Setbacks, and Trauma to Ignite Health and Happiness Jim provides a comprehensive program steeped in personal experience and science to help people with or without chronic illnesses to find the knowledge needed to achieve better health and an abundance of happiness.
In the past, Jim served as Vice President of Sales at Everyday Health where he was successful in developing an early stage sales team into a market-leading organization focused on customized, cross platform, patient education solutions. While at Everyday Health, Jim also held roles of General Manager, CarePages.com; Publisher of WhatToExpect.com, the online complement to the New York Times best seller, What To Expect When You’re Expecting and VP, Sales and Strategy for mobile initiatives.
Jim began his career trading health technology options on the American Stock Exchange in New York and eventually went to work for a company he traded, OnHealth.com. At OnHealth.com, he assisted in the advertising sales and business development activities that lead to its acquisition by WebMD Health. Having been retained by WebMD Health after the acquisition, Jim served as Director of Strategic Partnerships.
Jim is a graduate of the Whittemore School of Business at the University of New Hampshire.
Senior Director, Marketing, Synergy Pharmaceuticals
Julie is a 23 year veteran in the pharmaceutical marketing industry and as such has amassed an extensive background in a number of therapeutic areas and lifecycle stages. In her current role at Synergy Pharmaceuticals, Julie is focused on marketing the companies first asset, Trulance to market access and patient customers, as well as leading the brands public relations programs. Julie joined Synergy in 2016 after an 11-year tenure at Pfizer, where she held roles of increasing responsibility as part of Pfizer’s neuroscience, women’s health, vaccines, and inflammation marketing teams.
Several of the marketing programs that Julie has developed in her career have been recognized with prestigious industry awards, and for her individual impact to pharmaceutical marketing, Julie was recently named a “Trailblazer Brand Champion” by PM360 magazine, and previously named a "Top 25 DTC Marketer," and “Top Point-of-Care Marketer,” by DTC Perspectives Magazine, as well as a "Rising Star" by the Healthcare Businesswoman’s Association. In addition, she has served as a guest lecturer on healthcare marketing at St. Joseph University and New York University’s Leonard N. Stern School of Business.
Julie received her B.A. in Communications from William Paterson University, and has completed post-graduate executive education programs at the Wharton School of Business. She and her family split their time between Yardley, PA and Dorset, VT. When she isn’t running boys to various sports activities, Julie volunteers for the Eastern Pennsylvania Chapter of the March of Dimes, as well as serves as a Board Advisor and former Board of Directors member for the Robert J. Leonard Foundation of Bucks County.
Laila Zemrani is the Co-founder and CEO of Fitnescity, a company that aims at advancing wellness through data-driven personalization. Fitnescity brings Personal Informatics to the everyday gym experience.
Laila was named a Legatum fellow in Entrepreneurial Leadership and a MasterCard Foundation fellow at MIT. She is a frequent speaker on the topic of personalized wellness and Quantified Self. Prior to Fitnescity, Laila was a founding employee at Dataxis, a global data analysis firm.
Laila has an MBA from MIT Sloan. As an undergraduate, she studied engineering and management at Télécom ParisTech.
Co-founder and CEO of Spreemo Health
Ron Vianu is the co-founder and CEO of Spreemo Health, which is focused on improving patient care by delivering innovative and objective metrics of quality that help patients access the right providers and help providers deliver the right care. In his current work to define, deliver, and standardize quality health care, Ron draws on more than 20 years of experience running healthcare and technology startups. Born and raised in NYC, Ron resides in the East Village.
Adjunct Professor of Healthcare Economics, NYU Stern School of Business
Steve Andrzejewski has been making his mark in the pharma industry for the past 30 years. He’s done everything from establishing marketing best practices, to serving as a company turnaround artist, to even co-founding his own pharma company. In fact, Steve’s mark is imprinted on every pharma TV spot you see.
At Schering-Plough Corporation, Steve’s team was the first to do DTC TV with Claritin. The message was simple, “Ask your doctor about Claritin.” That same message continues to be used in every pharma TV spot to this day. That is only one of the best practices Steve helped establish while working on Claritin. Additionally, they did unbranded communications by talking about allergy as a disease and formed a sponsorship with Major League Baseball. All of that and more helped to take Claritin from its original goal of annual sales of around $150 million to $3 billion.
Steve went from leading brands to leading companies. When he started at King Pharmaceuticals it was a smaller company that was very successful from a business development standpoint, but didn’t have as much experience in the commercialization and optimizing of products. Between 2005 and 2007, Steve helped to grow revenue 21% and profits 19%, eventually leading to a sale to Pfizer. The story is similar at Nycomed USA where Steve helped to solve manufacturing and finance issues by optimizing the organization and changing the overall culture. The moves revitalized the company, which was acquired by Sandoz in 2012.
In 2011, Steve channeled his entrepreneurial instincts to co-found Spiritus Pharmaceuticals. The idea to start the company revolved around the fact that people using the wrong inhaler regiment results in asthma hospitalizations and ER visits. In addition to focusing on asthma, the company is also involved in anaphylaxis, sinusitis, and COPD. In January 2017, the FDA approved four new drugs from the company.
In 2016, Steve added teaching to his vast resume. He leads courses on health economics as an adjunct professor at NYU’s Stern Business School. He also continues to serve on the board for Health eVillages, which provides mobile health technology to areas without direct access to healthcare.
Founder and CEO, VirtualHealth
Founder and CEO of VirtualHealth, Adam Sabloff, is most responsible for the company's groundbreaking platform, which is the first true end-to-end population health and care management platform purpose built for integrated value-based care. His dedication and contributions to healthcare date back to the mid-2000s, when he developed the first ever Ritz-Carlton Residences in Baltimore and discovered a significant care gap that left seniors and the chronically ill with a lack of access to innovative, patient-centric medical care. After the loss of a loved one to a late-stage diagnosis, Adam, with the backing of two Fortune 100 tech companies, launched VirtualHealth to provide impactful healthcare delivery for all populations.
Under his leadership, the company has completed a Series A round led by growth equity firm Edison Partners, seen rapid customer adoption (1000 percent year- over-year growth) and deployment by some of the biggest health plans in the country.
Adam’s commitment and ingenuity has enabled him to have been recognized as the youngest recipient of the Baltimore Business Journal's “40 Under 40” award in 2006. He has also received the Daily Record’s “Most Influential” award and Capitol Files’ “Power Player” recognition.
Our 2017 Sponsors
Companies interested in sponsorship or participating in the networking reception please contact email@example.com
Like what you're reading and want to see more!?
Where will the conference take place?
The conference will be held on NYU Stern campus in the Kaufman Management Center located at 44 West 4th Street - events will be held in KMC 11-75 and 5-50.
Where should I check-in?
Check-in will take place in the Lobby of the Kaufman Management Center. Upon entering the building from Gould Plaza walk left toward the main security desk. Please bring a photo ID. Once through security, you will see the check-in table and signs for the event in the Lobby. Attendants at the check-in desk will direct you where to go depending on your time of arrival.
I'm a Prospective/undergraduate Student, can I attend?
Of course! We'd love for you to join us at conference to learn more about NYU and the Stern Healthcare Association. Please email Erin Guthrie at firstname.lastname@example.org for additional details.
The Kaufman Management Center (44 West 4th Street) is easily accessible by public transportation (A,B,C,D, E, F or M at West 4th Street; N or R at 8th St-NYU or the 6 at Astor Place). If you are traveling by car, public parking is available on West 3rd Street and on Thompson Street.
Pictures from last year's conference:
SHA aims to bring together Stern MBA students who have an interest in the healthcare industries. Our objectives include:
- Promoting the advancement of health care, pharmaceutical science, and biotechnology and understand the issues and challenges facing these industries
- Helping members explore the career opportunities within these sectors
- Increasing the academic awareness and student interest in these dynamic industries
- Serving as a recruitment connection for all healthcare related professions, including pharmaceutical, biotechnology and medical device firms as well as healthcare related professional service firms in consulting and finance.